download.png
Research-news.png
1.png

Youth Education Awards

Accepting applications!

Brain Tumour Youth Education Awards are now open. Survivors of a pediatric brain tumour (diagnosed with a brain tumour before the age of 25), between the ages of 16 and 30, who are pursuing post-secondary education are eligible for this award opportunity. 

APPLY NOW

FUNDING OPPORTUNITIES

Cancer Research Society Translational Research Grants


Brain Canada in partnership with the Cancer Research Society (CRS) is launching a national granting program to fund translational research that advances effective translation and application of knowledge of brain cancer across the expanse of pre-clinical, clinical and health services delivery domains to improve patient outcomes.

Applicants are invited to submit a Registration Form to programs@braincanada.ca before 16:00 ET on March 16, 2022.

For additional information, please download the Request for Applications (RFA) form below.

CLICK TO DOWNLOAD

CADTH PMDE Network Partners:

Request for Proposals

The new CADTH Post-Market Drug Evaluation (PMDE) Program will be launching a re-imagined evidence generation network in September 2022. The program will bring together an external network of Canada’s expert applied researchers, methodologists, and data analysts to provide evidence to answer questions posed by federal, provincial, and territorial decision-makers about post-market drug safety and effectiveness.

As the network is being developed, the PMDE Program will be recruiting network partners. If you are interested in joining the PMDE network to produce evidence for decision-makers, please download the Request for proposal from the button below.

DOWNLOAD

RESEARCH FEATURE SNAPSHOT

Radiotherapy Responses in the Mammalian Brain

Presented by:

Dr. Shane M. Harding

Princess Margaret Cancer Centre, University Health Network

University of Toronto

Depts. of Medical Biophysics, Radiation Oncology and Immunology


RESEARCH NEWS

The removal of brain tumours, a skill expected of neurosurgical graduates, remains among the most complex and challenging procedures within medicine. Virtual reality neurosurgical simulators provide realistic simulated brain tumour surgeries in environments with no risks to patients. Students can repeat procedures as many times as needed to acquire the necessary skills.



Dr. Rolando Del Maestro, who is the director of the Neurosurgical Simulation Research Centre at The Neuro and one of our co-founders, and his team published a study in the Journal of the American Medical Association today on the "Effect of Artificial Intelligence Tutoring vs Expert Instruction on Learning Simulated Surgical Skills Among Medical Students.

 

LEARN MORE

IN THE NEWS

Raymond-Reilly-1-e1570472990176-1024x979.jpg

The Globe and Mail published an article on Feb 16. Prof. Raymond Reilly, director of the Centre for Pharmaceutical Oncology at the University of Toronto’s Leslie Dan Faculty of Pharmacy, was part of the world's first clinical trial that delivered a therapy drug targeting metastatic tumours in the brain. The team showed how ultrasound-focused therapy allows the drug to get past the blood-brain barrier.

READ MORE

CLINICAL TRIALS

clinical-trials-ontario-logo.png

On February 4th, World Cancer Day, Clinical Trials Ontario hosted a #TalkClinicalTrials live event on their Facebook page. The event was conducted to discuss experiences in engaging with cancer trials and sharing information and resources that can help people learn about trials and make well-informed decisions.

WATCH NOW!
PowerOfHope- Quote1.png

CURRENT FUNDING OPPORTUNITIES | BRAIN TUMOUR REGISTRY | BRAIN TUMOUR TISSUE BANK

Facebook  Twitter  Instagram  YouTube